Saniona: Recruitment to phase III study in Mexico completed

Research Note

2018-02-01

11:37

Earlier today, Saniona announced that the recruitment of patients (n=372) in the phase III study with tesofensine in obese patients has been completed. The trial is expected to be finalized in 2018 followed by top-line data to be presented in early 2019.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.